These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Menkes disease: experience in copper salts therapy]. Guitet M; Campistol J; Medina M Rev Neurol; 1999 Jul 16-31; 29(2):127-30. PubMed ID: 10528324 [TBL] [Abstract][Full Text] [Related]
25. [West syndrome as an epileptic presentation in Menkes' disease. Two cases report]. Venta-Sobero JA; Porras-Kattz E; Gutiérrez-Moctezuma J Rev Neurol; 2004 Jul 16-31; 39(2):133-6. PubMed ID: 15264163 [TBL] [Abstract][Full Text] [Related]
26. A Truncating De Novo Point Mutation in a Young Infant with Severe Menkes Disease. Lin YJ; Ho CS; Hsu CH; Lin JL; Chuang CK; Tsai JD; Chiu NC; Lin HY; Lin SP Pediatr Neonatol; 2017 Feb; 58(1):89-92. PubMed ID: 25771438 [TBL] [Abstract][Full Text] [Related]
27. Disturbed copper transport in humans. Part 1: mutations of the ATP7A gene lead to Menkes disease and occipital horn syndrome. Seidel J; Møller LB; Mentzel HJ; Kauf E; Vogt S; Patzer S; Wollina U; Zintl F; Horn N Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL141-8. PubMed ID: 11936860 [TBL] [Abstract][Full Text] [Related]
28. Pathology, clinical features and treatments of congenital copper metabolic disorders--focus on neurologic aspects. Kodama H; Fujisawa C; Bhadhprasit W Brain Dev; 2011 Mar; 33(3):243-51. PubMed ID: 21112168 [TBL] [Abstract][Full Text] [Related]
29. A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease. Dagenais SL; Adam AN; Innis JW; Glover TW Am J Hum Genet; 2001 Aug; 69(2):420-7. PubMed ID: 11431706 [TBL] [Abstract][Full Text] [Related]
30. [Copper metabolism and genetic disorders]. Shimizu N Nihon Rinsho; 2016 Jul; 74(7):1151-5. PubMed ID: 27455805 [TBL] [Abstract][Full Text] [Related]
32. Menkes kinky hair syndrome: Is it a treatable disorder? Garnica AD; Frias JL; Rennert OM Clin Genet; 1977 Feb; 11(2):154-61. PubMed ID: 189959 [TBL] [Abstract][Full Text] [Related]
33. Menkes disease and response to copper histidine: An Indian case series. Yoganathan S; Sudhakar SV; Arunachal G; Thomas M; Subramanian A; George R; Danda S Ann Indian Acad Neurol; 2017; 20(1):62-68. PubMed ID: 28298846 [TBL] [Abstract][Full Text] [Related]
34. Menkes' syndrome: an updated review. Hart DB J Am Acad Dermatol; 1983 Jul; 9(1):145-52. PubMed ID: 6886097 [TBL] [Abstract][Full Text] [Related]
35. Mutation in the CPC motif-containing 6th transmembrane domain affects intracellular localization, trafficking and copper transport efficiency of ATP7A protein in mosaic mutant mice--an animal model of Menkes disease. Lenartowicz M; Grzmil P; Shoukier M; Starzyński R; Marciniak M; Lipiński P Metallomics; 2012 Feb; 4(2):197-204. PubMed ID: 22089129 [TBL] [Abstract][Full Text] [Related]
36. Small amounts of functional ATP7A protein permit mild phenotype. Møller LB J Trace Elem Med Biol; 2015; 31():173-7. PubMed ID: 25172213 [TBL] [Abstract][Full Text] [Related]
37. Regulation of copper metabolism in the mottled mouse. Packman S Arch Dermatol; 1987 Nov; 123(11):1545-1547a. PubMed ID: 3674914 [TBL] [Abstract][Full Text] [Related]
38. An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome. Tümer Z Hum Mutat; 2013 Mar; 34(3):417-29. PubMed ID: 23281160 [TBL] [Abstract][Full Text] [Related]
39. [Inherited neurological disease--relationship between an essential trace elements and Wilson/Menkes disease]. Ozawa M; Aoki T Nihon Rinsho; 1996 Jan; 54(1):117-22. PubMed ID: 8587176 [TBL] [Abstract][Full Text] [Related]
40. Molecular basis of neurodegeneration and neurodevelopmental defects in Menkes disease. Zlatic S; Comstra HS; Gokhale A; Petris MJ; Faundez V Neurobiol Dis; 2015 Sep; 81():154-61. PubMed ID: 25583185 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]